Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine

M Sainz-Mejías, I Jurado-Martín, S McClean - Cells, 2020 - mdpi.com
Pseudomonas aeruginosa is a leading cause of chronic respiratory infections in people with
cystic fibrosis (CF), bronchiectasis or chronic obstructive pulmonary disease (COPD), and …

[HTML][HTML] Cloning, expression, and purification of Pseudomonas aeruginosa flagellin, and characterization of the elicited anti-flagellin antibody

B Behrouz, N Amirmozafari… - Iranian Red Crescent …, 2016 - ncbi.nlm.nih.gov
Background: Pseudomonas aeruginosa is an important opportunistic human pathogen that
causes serious infections in immunocompromised hosts. The single polar flagellum is an …

Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses

S Velashjerdi Farahani… - Pathogens and global …, 2016 - Taylor & Francis
In the present study we used a fusion peptide from HIV-1 p24 and Nef as vaccine model and
adjuvant activity of Naloxone/alum mixture was evaluated in a peptide vaccine model. HIV-1 …

[PDF][PDF] Adjuvant Effect of Royal Jelly on HIV-1 Multi-Epitope Vaccine Candidate: Induction of Th1 Cytokine Pattern

M Mahdavi, M Cheragh, KP Bagheri… - MOJ …, 2017 - researchgate.net
Studies show that, royal jelly as a naturally substance could improves immune responses.
So, here, royal jelly as adjuvant was used in mixture with a recombinant multi-epitope HIV-1 …

Distribuição de fatores de virulência de acordo com o perfil de formação de biofilme em isolados clínicos de Pseudomonas aeruginosa

SM Mauad - 2022 - bdtd.ueg.br
Pseudomonas aeruginosa são bactérias Gram-negativas presentes em diferentes nichos,
mas que são capazes de colonizar e infectar organismos. São consideradas patógenos …